secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2023-07-24T23:59:59+00:00
Accession:  0001193125-23-191945
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma terminates merger with Infinity after stockholder vote fails
-----------------------------------------------------------------------

- Stockholders voted against merger: 47.86% for, 51.44% against; turnout 59.70% of outstanding shares.
- MEI terminated the Merger Agreement with Infinity on July 23, 2023, effective immediately.
- Company will continue development of Voruciclib and ME-344; clinical data expected around year-end.
- CEO David M. Urso stated focus on capturing stockholder value from pipeline programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523191945/0001193125-23-191945-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523191945/d442693d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-191945

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer